Tacrolimus Ointment

A Topical Immunomodulator for Atopic Dermatitis

T. Ruzicka, S. Reitamo (Herausgeber)

Media-Kombination

X, 258 Seiten

2003 | 1., Ed.
Springer Berlin
978-3-540-43513-6 (ISBN)

Infos

Therapeutic breakthroughs in medicine are usually accompanied by a wealth of data. Often they result in a change of disease treatment paradigms. Tacrolimus ointment is the first in the new class of steroid-free Topical Immunomodulators (TIMs), and as such represents the first true breakthrough since the introduction of topical steroids more than 50 years ago for the treatment of T-cell mediated inflammatory skin diseases such as atopic dermatitis. This book gives an easy-to-read overview of the discovery and the development of Tacrolimus ointment for the treatment of atopic dermatitis. Summarising the largest clinical trial program ever conducted in dermatology for a new treatment with more than 13000 patients, it offers a detailed insight into the efficacy and safety profile of Tacrolimus ointment. Based on this large body of data and extensive personal experience, the authors offer practical and hands-on guidance for the physician as to when and how to use Tacrolimus ointment in daily practice. TOC:From the contents: Epidemiology.- Pathogenesis.- Current Treatment of AD.- How to Evaluate AD.- Development of Tacrolimus Ointment.- Tacrolimus as an Immunomodulator.- Clinical Experience.- Social Impact of AD.- Other Indications (Excluding AD).

Produkt-Details

• Sprache: englisch
• Maße: 193 x 242 mm
• Gewicht: 935 g
• Einbandart: gebunden
• Schlagworte: Dermatitis • Dermatologie • Dermatologie / Hautkrankheiten • Neurodermitis • Salben
• ISBN-10: 3-540-43513-1 / 3540435131
• ISBN-13: 978-3-540-43513-6 / 9783540435136
• Zustand: Neuware